HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lofexidine versus clonidine in rapid opiate detoxification.

Abstract
The aim of the present study is to evaluate lofexidine and clonidine, in an accelerated opiate detoxification procedure (3 days), without anaesthesia. Forty heroin-dependent individuals were detoxified, evaluating withdrawal symptoms, craving levels, mood changes, urine toxicologic screens, and dropout during therapy with either (1) clonidine, oxazepam, baclofen, and ketoprofene, with naloxone and naltrexone for 3 days (20 subjects) or (2) lofexidine, oxazepam, baclofen, and ketoprofene with naloxone and naltrexone for 3 days (20 subjects). Both clonidine and lofexidine rapid detoxifications were found effective. The subjects treated with lofexidine showed significantly lower levels of withdrawal symptoms, fewer mood problems, less sedation and hypotension. No significant differences in craving levels, morphine metabolites in urine, or dropout rate were evidenced between the two groups. The early use of naltrexone during detoxification in combination with either alpha-2-agonist facilitated the acceptance for long-term naltrexone treatment. Lofexidine appeared to be more useful than clonidine in a 3-day accelerated opiate detoxification, not only to counteract withdrawal symptoms, but also in the treatment of dysphoria and mood changes. Because lofexidine does not produce hypotension, safe outpatient treatment, without hospital support, could be possible.
AuthorsG Gerra, A Zaimovic, F Giusti, C Di Gennaro, U Zambelli, S Gardini, R Delsignore
JournalJournal of substance abuse treatment (J Subst Abuse Treat) Vol. 21 Issue 1 Pg. 11-7 (Jul 2001) ISSN: 0740-5472 [Print] United States
PMID11516922 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Naloxone
  • Opium
  • Clonidine
  • lofexidine
Topics
  • Adult
  • Analysis of Variance
  • Clonidine (analogs & derivatives, therapeutic use)
  • Double-Blind Method
  • Humans
  • Inactivation, Metabolic (physiology)
  • Male
  • Naloxone (administration & dosage)
  • Opioid-Related Disorders (drug therapy, physiopathology)
  • Opium (administration & dosage)
  • Substance Withdrawal Syndrome (drug therapy, physiopathology)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: